Fidelity Investments
NAUT icon

Fidelity Investments’s Nautilus Biotechnolgy NAUT Stock Holding History

Fidelity Investments’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Sell
3,343
-143
-4% -$351 ﹤0.01% 4681
2025
Q4 		$6.8K Sell
3,486
-5,174
-60% -$8.48K ﹤0.01% 4827
2025
Q3 		$7.32K Sell
8,660
-15,838
-65% -$11.6K ﹤0.01% 4686
2025
Q2 		$17.8K Buy
24,498
+12,584
+106% +$9.45K ﹤0.01% 4331
2025
Q1 		$10.3K Buy
11,914
+4,881
+69% +$7.25K ﹤0.01% 4484
2024
Q4 		$11.8K Buy
7,033
+392
+6% +$938 ﹤0.01% 4406
2024
Q3 		$18.9K Buy
6,641
+2,419
+57% +$6.26K ﹤0.01% 4196
2024
Q2 		$9.88K Sell
4,222
-189
-4% -$493 ﹤0.01% 4338
2024
Q1 		$13K Buy
4,411
+39
+0.9% +$111 ﹤0.01% 4179
2023
Q4 		$13.1K Buy
4,372
+120
+3% +$343 ﹤0.01% 4152
2023
Q3 		$13.4K Buy
4,252
+53
+1% +$173 ﹤0.01% 3991
2023
Q2 		$16.3K Buy
4,199
+670
+19% +$1.93K ﹤0.01% 3955
2023
Q1 		$9.78K Sell
3,529
-17,353
-83% -$36.4K ﹤0.01% 4139
2022
Q4 		$37.6K Buy
20,882
+19,897
+2,020% +$38.4K ﹤0.01% 3535
2022
Q3 		$2K Buy
+985
New +$2.48K ﹤0.01% 4570
2021
Q2 		– Sell
-418,718
Closed -$5.77M – 4657
2021
Q1 		$5.77M Buy
+418,718
New +$5.8M ﹤0.01% 2214

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments's NAUT Position: Q1 2026 in Review

Fidelity Investments reduced its Nautilus Biotechnolgy (NAUT) stake by 4.1% in Q1 2026, selling an estimated $351 and leaving 3,343 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #4681.

Fidelity Investments first reported a position in NAUT in Q1 2021 and has held it in 16 quarters since. The position peaked at $5.77M in Q1 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Fidelity Investments held 3,343 shares of Nautilus Biotechnolgy worth $13K as of Q1 2026.
  • Fidelity Investments sold 143 Nautilus Biotechnolgy shares in Q1 2026, an estimated $351.
  • Nautilus Biotechnolgy made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4681 holding.
  • Fidelity Investments first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 16 quarters since.
  • Fidelity Investments's Nautilus Biotechnolgy position peaked at $5.77M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.